PASSAGE BIO, INC. Payments of Stock Issuance Costs
PASSAGE BIO, INC. (PASG) reported Payments of Stock Issuance Costs of $338.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2023-03-06
- PASSAGE BIO, INC. payments of stock issuance costs for the quarter ending 2021-12-31 was $0.00.
- PASSAGE BIO, INC. payments of stock issuance costs for the quarter ending 2021-09-30 was $0.00.
- PASSAGE BIO, INC. payments of stock issuance costs for the quarter ending 2021-06-30 was $86.00K.
- PASSAGE BIO, INC. payments of stock issuance costs for the quarter ending 2021-03-31 was $252.00K.
- PASSAGE BIO, INC. payments of stock issuance costs for fiscal 2021 was $338.00K.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $0.00 derived: sum of 2 quarters · filed 2023-03-06 | $86.00K derived: sum of 3 quarters · filed 2023-03-06 | $338.00K 10-K · filed 2023-03-06 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $86.00K derived: sum of 2 quarters · filed 2022-11-10 | $338.00K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $86.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $338.00K 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $252.00K 10-Q · filed 2022-05-16 | |||
| 2019-09-30 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $20.00K 10-Q · filed 2020-11-10 | ||
| 2019-06-30 | $5.00K 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |